» Articles » PMID: 37057206

Endothelial Progenitor Cell Derived Exosomes Mediated MiR-182-5p Delivery Accelerate Diabetic Wound Healing Via Down-regulating PPARG

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2023 Apr 14
PMID 37057206
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic wound is one of the most common and serious complications of diabetes, which is characterized by abnormal number and quality of wound repair related cells. Previous studies have shown that human endothelial progenitor cells derived exosomes (EPCs-EXO) can promote diabetic wound healing through modulating vascular endothelial cell function. The purpose of this study was to investigate the biological effects and molecular mechanisms of EPCs-EXO on diabetic wound healing. The regulation of EPCs-EXO on human immortalized epidermal cell line HaCaT in high glucose (HG) environment was evaluated. Our data showed that EPCs-EXO promoted the proliferation, migration, while inhibited apoptosis of HaCaTs challenged by HG via elevating miR-182-5p expression level . Skin wound healing was significantly enhanced by EPCs-EXO in diabetic mice. Moreover, bioinformatics analyses and luciferase reporter assay indicated that exosomal miR-182-5p was bound to PPARG 3' UTR sequence and inhibited the expression of PPARG. Collectively, our findings provided a new role of EPCs-EXO in the clinical treatment of diabetic skin wounds. Diabetic wound is one of the most common and serious complications of diabetes, which is characterized by abnormal number and quality of wound repair related cells. Previous studies have shown that human endothelial progenitor cells derived exosomes (EPCs-EXO) can promote diabetic wound healing through modulating vascular endothelial cell function. The purpose of this study was to investigate the biological effects and molecular mechanisms of EPCs-EXO on diabetic wound healing. The regulation of EPCs-EXO on human immortalized epidermal cell line HaCaT in high glucose (HG) environment was evaluated. Our data showed that EPCs-EXO promoted the proliferation, migration, while inhibited apoptosis of HaCaTs challenged by HG via elevating miR-182-5p expression level . Skin wound healing was significantly enhanced by EPCs-EXO in diabetic mice. Moreover, bioinformatics analyses and luciferase reporter assay indicated that exosomal miR-182-5p was bound to PPARG 3' UTR sequence and inhibited the expression of PPARG. Collectively, our findings provided a new role of EPCs-EXO in the clinical treatment of diabetic skin wounds.

Citing Articles

A multifunctional photothermal electrospun PLGA/MoS@Pd nanofiber membrane for diabetic wound healing.

Chen Z, Mo Q, Mo D, Pei X, Liang A, Cai J Regen Biomater. 2025; 12:rbae143.

PMID: 39850758 PMC: 11754638. DOI: 10.1093/rb/rbae143.


Emerging biologic and clinical implications of miR-182-5p in gynecologic cancers.

Zehtabi M, Ghaedrahmati F, Gale Dari M, Moramezi F, Kempisty B, Mozdziak P Clin Transl Oncol. 2024; .

PMID: 39661239 DOI: 10.1007/s12094-024-03822-9.


Exosome-based cell therapy for diabetic foot ulcers: Present and prospect.

Yang Z, Yang M, Rui S, Hao W, Wu X, Guo L Heliyon. 2024; 10(20):e39251.

PMID: 39498056 PMC: 11532254. DOI: 10.1016/j.heliyon.2024.e39251.


The emerging modulators of non-coding RNAs in diabetic wound healing.

Aghayants S, Zhu J, Yu J, Tao R, Li S, Zhou S Front Endocrinol (Lausanne). 2024; 15:1465975.

PMID: 39439564 PMC: 11493653. DOI: 10.3389/fendo.2024.1465975.


Endothelial extracellular vesicles: their possible function and clinical significance in diabetic vascular complications.

Fang X, Zhang Y, Zhang Y, Guan H, Huang X, Miao R J Transl Med. 2024; 22(1):944.

PMID: 39415278 PMC: 11481601. DOI: 10.1186/s12967-024-05760-0.


References
1.
Yang C, Luo L, Bai X, Shen K, Liu K, Wang J . Highly-expressed micoRNA-21 in adipose derived stem cell exosomes can enhance the migration and proliferation of the HaCaT cells by increasing the MMP-9 expression through the PI3K/AKT pathway. Arch Biochem Biophys. 2020; 681:108259. DOI: 10.1016/j.abb.2020.108259. View

2.
Rodriguez-Rodriguez N, Martinez-Jimenez I, Garcia-Ojalvo A, Mendoza-Mari Y, Guillen-Nieto G, Armstrong D . Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients. MEDICC Rev. 2021; 24(1):44-58. DOI: 10.37757/MR2021.V23.N3.8. View

3.
Xiong J, Hu H, Guo R, Wang H, Jiang H . Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications. Front Endocrinol (Lausanne). 2021; 12:646233. PMC: 8117220. DOI: 10.3389/fendo.2021.646233. View

4.
Gensch C, Clever Y, Werner C, Hanhoun M, Bohm M, Laufs U . The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis. 2006; 192(1):67-74. DOI: 10.1016/j.atherosclerosis.2006.06.026. View

5.
Chang W, Wang J . Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus. Cells. 2019; 8(8). PMC: 6721737. DOI: 10.3390/cells8080853. View